Dermavant to Present New Positive Data from Phase 4, Open Label Trial of VTAMA® (tapinarof) Cream, 1% for Intertriginous Plaque Psoriasis in Adults and Multiple Clinical Trials of VTAMA cream at the 2023 Fall Clinical Dermatology Conference

October 16, 2023 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Dermavant to Present New Positive Data from Phase 4, Open Label Trial of VTAMA® (tapinarof) Cream, 1% for Intertriginous Plaque Psoriasis in Adults and Multiple Clinical Trials of VTAMA cream at the 2023 Fall Clinical Dermatology Conference

LONG BEACH, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–Dermavant to Present Positive Data from Phase 4 Trial of VTAMA® Cream, 1% for Intertriginous Plaque Psoriasis in Adults at 2023 Fall Clinical
Click here to view original post